Selected diagnoses included T2DM/nonspecific DM, overweight/obesity, hypertension, heart failure, hyperlipidemia, and atherosclerotic CVD
Individual responses vary based on genetics, baseline gut health, diet, and dose escalation speed
Patients who already take antihypertensive medications should be particularly attentive to blood pressure monitoring when commencing Ozempic
This 1.4-million-square-foot facility slated for 2029 completion will produce Wegovy (semaglutide for obesity) and Ozempic (semaglutide for diabetes)
Based on these findings, small-molecule inhibitors of the IDH1 mutated enzyme are currently under investigation in preclinical and clinical phases as promising treatments for IDH1-mutated intrahepatic cholangiocarcinomas [203, 204]